PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339172
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1339172
The global protein labelling market size is expected to reach USD 4.69 billion by 2032, according to a new study by Polaris Market Research. The report "Protein Labelling Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents, Kits, Services); By Method; By Application (Mass Spectrometry, Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Protein Microarray); By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Recent developments in spin labels have expanded the capabilities of site-directed spin labeling of proteins, which in combination with electron paramagnetic resonance spectroscopy (SDSL-EPR). Private players and government agencies are also increasing their investments in proteomics and genomics R&D, with proteomics being the study of the entire protein content of a cell, tissue, or organism. Proteomic profiling approaches often require protein labeling methods before separation and analysis. For example, the United States National Institutes of Health (NIH) has allocated USD 37 billion to scientific research, which will likely drive further development in the field of protein labeling.
Cell-based assays are becoming increasingly popular in proteomics and genomics research as they provide information about intracellular molecular targets and can be performed in a biological context, unlike other techniques that analyze proteins outside of their natural environment. The increased funding for life sciences research has also led to the development of new and improved protein labeling techniques, which has further driven the market growth.
The study of Post-translational Modification (PTM) of proteins is becoming increasingly popular in the fields of cell biology and disease treatment and prevention. Effective quantification methods of protein expression using tagging strategies such as iodoTMTzero Label Reagent have contributed to the efficient determination of PTMs. As a result, there has been a rise in PTM-related studies, which is driving the market. The market growth is also expected to be positively influenced by the emergence of novel techniques and the launch of improved products.
Use of fluorescent antibodies in combination with mass spectrometry has shown potential in the field of proteomics. This technique, known as immunoaffinity mass spectrometry, enables the specific isolation and quantification of target proteins from complex biological samples. The combination of these two powerful technologies has facilitated the identification of low-abundance proteins and post-translational modifications, leading to new insights in disease biology and drug discovery.
Proteins reagents segment held the largest share, as it allows in-situ fusion of expression cells, which eliminates the need for in-vitro labeling
Fluorescence microscopy application recorded the highest growth rate, owing to the development of fluorescent proteins
In-vitro labelling method segment is projected to experience larger revenue share, due to high demand in proteomic analysis
The global players include: Thermo Fisher Scientific, Merck, Perkin Elmer, Promega Corporation, Roche, LGC Limited, New England Biolabs, LI-COR, GE Healthcare, and Jena Bioscience.
Polaris Market Research has segmented the protein labelling market report based on product, method, application, and region: